Low levels of plasma omega 3-polyunsaturated fatty acids are associated with cerebral small vessel diseases in acute ischemic stroke patients

Nutrition Research

Volumn 35, Issue 5, 2015, Pages 368-374

  Song, Tae Jin ^a,b   Chang, Yoonkyung ^a   Shin, Min Jeong ^c   Heo, Ji Hoe ^b   Kim, Yong Jae ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

Cerebral microbleeds; Fatty acids composition; N 3 polyunsaturated fatty acids; Perivascular spaces; Small vessel disease; White matter changes

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYPERTENSION; LACUNAR STROKE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX; WHITE MATTER LESION; ASYMPTOMATIC DISEASE; BLOOD; BRAIN CIRCULATION; CEREBROVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DOWN REGULATION; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; SOUTH KOREA; STROKE; STROKE, LACUNAR; UNIVERSITY HOSPITAL; VASCULARIZATION; VERY ELDERLY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBRAL SMALL VESSEL DISEASES; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FATTY ACIDS, OMEGA-3; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; STROKE; STROKE, LACUNAR; WHITE MATTER;

EID: 84929655795     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.04.008     Document Type: Article

References (35)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010, 9:689-701.
2. Kim B.J., Lee S.H. Cerebral microbleeds: their associated factors, radiologic findings, and clinical implications. J Stroke 2013, 15:153-163.
3. Casula M., Soranna D., Catapano A.L., Corrao G. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: a meta-analysis of randomized, placebo controlled trials [corrected]. Atheroscler Suppl 2013, 14:243-251.
4. Karr J.E., Alexander J.E., Winningham R.G. Omega-3 polyunsaturated fatty acids and cognition throughout the lifespan: a review. Nutr Neurosci 2011, 14:216-225.
5. Park Y., Park S., Yi H., Kim H.Y., Kang S.J., Kim J., et al. Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res 2009, 29:825-830.
6. Kim Y.J., Kim O.Y., Cho Y., Chung J.H., Jung Y.S., Hwang G.S., et al. Plasma phospholipid fatty acid composition in ischemic stroke: importance of docosahexaenoic acid in the risk for intracranial atherosclerotic stenosis. Atherosclerosis 2012, 225:418-424.
7. Tan Z.S., Harris W.S., Beiser A.S., Au R., Himali J.J., Debette S., et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012, 78:658-664.
8. Bowman G.L., Silbert L.C., Howieson D., Dodge H.H., Traber M.G., Frei B., et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78:241-249.
9. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
10. Gorelick P.B. Primary and comprehensive stroke centers: history, value and certification criteria. J Stroke 2013, 15:78-89.
11. Song T.J., Kim J., Lee H.S., Nam C.M., Nam H.S., Kim Y.D., et al. Distribution of cerebral microbleeds determines their association with impaired kidney function. J Clin Neurol 2014, 10:222-228.
12. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987, 149:351-356.
13. Doubal F.N., MacLullich A.M., Ferguson K.J., Dennis M.S., Wardlaw J.M. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010, 41(3):450-454.
14. Jeon S.B., Kwon S.U., Cho A.H., Yun S.C., Kim J.S., Kang D.W. Rapid appearance of new cerebral microbleeds after acute ischemic stroke. Neurology 2009, 73(20):1638-1644.
15. Staals J., Makin S.D., Doubal F.N., Dennis M.S., Wardlaw J.M. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 2014, 83(14):1228-1234.
16. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991, 325:445-453.
17. Warfarin-Aspirin Symptomatic Intracranial Disease Trial I. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003, 22:106-117.
18. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
19. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986, 27:114-120.
20. Do H.J., Chung H.K., Moon J., Shin M.J. Relationship between the estimates of desaturase activities and cardiometabolic phenotypes in Koreans. J Clin Biochem Nutr 2011, 49:131-135.
21. Kim Y.J., Lee S.M., Cho H.J., Do H.J., Hong C.H., Shin M.J., et al. Plasma levels of apolipoprotein E and risk of intracranial artery stenosis in acute ischemic stroke patients. Ann Nutr Metab 2013, 62:26-31.
22. Song T.J., Kim J., Song D., Nam H.S., Kim Y.D., Lee H.S., et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation. Neurology 2014, 83:1308-1315.
23. Song T.J., Kim J., Lee H.S., Nam C.M., Nam H.S., Heo J.H., et al. The frequency of cerebral microbleeds increases with CHADS(2) scores in stroke patients with non-valvular atrial fibrillation. Eur J Neurol 2013, 20:502-508.
24. Witte A.V., Kerti L., Hermannstadter H.M., Fiebach J.B., Schreiber S.J., Schuchardt J.P., et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014, 24:3059-3068.
25. Virtanen J.K., Siscovick D.S., Lemaitre R.N., Longstreth W.T., Spiegelman D., Rimm E.B., et al. Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the Cardiovascular Health Study. J Am Heart Assoc 2013, 2:e000305.
26. Ezzeddine M.A., Primavera J.M., Rosand J., Hedley-Whyte E.T., Rordorf G. Clinical characteristics of pathologically proved cholesterol emboli to the brain. Neurology 2000, 54:1681-1683.
27. Fanning J.P., Wesley A.J., Wong A.A., Fraser J.F. Emerging spectra of silent brain infarction. Stroke 2014, 45:3461-3471.
28. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
29. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-1037.
30. Eady T.N., Khoutorova L., Anzola D.V., Hong S.H., Obenaus A., Mohd-Yusof A., et al. Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats. PLoS One 2013, 8:e77237.
31. Chang C.Y., Kuan Y.H., Li J.R., Chen W.Y., Ou Y.C., Pan H.C., et al. Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. J Nutr Biochem 2013, 24:2127-2137.
32. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477-485.
33. Cawood A.L., Ding R., Napper F.L., Young R.H., Williams J.A., Ward M.J., et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010, 212:252-259.
34. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
35. Tousoulis D., Plastiras A., Siasos G., Oikonomou E., Verveniotis A., Kokkou E., et al. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis 2014, 232:10-16.